HIM
XTNT icon

Hillsdale Investment Management’s Xtant Medical Holdings XTNT Stock Holding History

Hillsdale Investment Management’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$202K Hold
362,200
– – 0.01% 559
2025
Q4 		$284K Buy
+362,200
New +$263K 0.01% 479

Other funds holding XTNT

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Hillsdale Investment Management's XTNT Position: Q1 2026 in Review

Hillsdale Investment Management held its Xtant Medical Holdings (XTNT) position steady in Q1 2026 at 362,200 shares worth $202K. The position accounts for 0.01% of the portfolio, ranked #559.

Hillsdale Investment Management first reported a position in XTNT in Q4 2025 and has held it in 2 quarters since. The position peaked at $284K in Q4 2025. 34 funds tracked by Wall St. Rank hold XTNT as of Q1 2026.

  • Hillsdale Investment Management held 362,200 shares of Xtant Medical Holdings worth $202K as of Q1 2026.
  • Hillsdale Investment Management left its Xtant Medical Holdings share count unchanged in Q1 2026.
  • Xtant Medical Holdings made up 0.01% of Hillsdale Investment Management's portfolio in Q1 2026, its #559 holding.
  • Hillsdale Investment Management first reported a position in Xtant Medical Holdings in Q4 2025 and has held it in 2 quarters since.
  • Hillsdale Investment Management's Xtant Medical Holdings position peaked at $284K in Q4 2025.
  • 34 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q1 2026.

Based on Hillsdale Investment Management's 13F filing for Q1 2026, filed 4 May 2026.